View Cart (0 items)

Pharmaceutical

Specialty Chemical Manufacturer Plans $16 Million Expansion at US Facility

April 26, 2010
Sensient Technologies Corp., a Milwaukee-based manufacturer of colors, flavors and fragrances for food and beverage, cosmetic and pharmaceutical and other products, recently announced plans for a $16 million expansion
Read More

Charles River to Buy China''s WuXi for $1.6 Billion

April 26, 2010
U.S.-based pharmaceutical research firm Charles River Laboratories, has agreed to buy Wuxi PharmaTech, a Chinese rival, for US$1.6 billion. The deal would allow Charles River to expand its presence
Read More

Drugmakers Lose Fight Over Cheap Medicines in Europe

April 26, 2010
Drug companies have lost a legal battle against schemes promoted by Britain''s state health service that encourage doctors to prescribe cheaper medicines, according to Reuters. The Association of the
Read More

Nycomed Gets Lung-Drug Deal with Merck

April 26, 2010
Reuters reports privately owned Swiss drugmaker Nycomed, which is aiming for an eventual IPO, has partnered with Merck & Co to help sell its key lung drug Daxas in
Read More

Novartis Buys Generic Lung Drug Firm Oriel

April 19, 2010
Swiss drugmaker Novartis AG has bought privately held U.S.-company Oriel Therapeutics to boost its generics portfolio in the multibillion-dollar market for respiratory drugs, reports Reuters. According to industry estimates approximately
Read More

Update on African Global Pharma Generic Pharmaceutical Manufacturing Facility

April 12, 2010
In a press release statement, Emerging World Pharma Inc.’s president Brandon Keks reports that three shipping containers of production equipment and supplies are currently en route to port in Ghana.
Read More

US Drug Sales Growth Up In 2009

April 5, 2010
The Associated Press reports growth in U.S. sales of pharmaceuticals bounced back last year as rebates and low-cost generic drugs drove an increase in the number of prescriptions filled, according
Read More

Teva to Buy Ratiopharm for Nearly $5 Billion

March 22, 2010
According to Reuters, Israel''s Teva has won the battle for German generic drugmaker Ratiopharm, paying an enterprise value of 3.625 billion euros to fix the industry leader''s weakness in the
Read More

Court Finds Drug Vioxx Doubled Heart Attack Risk

March 8, 2010
The Associated Press reports an Australian court has awarded 287,000 Australian dollars ($259,000) in compensation to a man leading a class action suit against the drug''s maker. Melbourne Federal
Read More

GlaxoSmithKline Expected to Cut 4,400 Jobs

February 1, 2010
U.K.-based GlaxoSmithKline, will announce plans this week to cut 4,000 more jobs, the Sunday Times of London reports. The newspaper says that the job reductions are likely to be announced
Read More